John Scarlett
Director Ejecutivo en GERON CORPORATION .
Fortuna: 445 000 $ al 30/04/2024
Cargos activos de John Scarlett
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GERON CORPORATION | Presidente | 27/12/2018 | - |
| Director Ejecutivo | 30/09/2011 | - | |
| Presidente | 30/09/2011 | - | |
| Director/Miembro de la Junta | 30/09/2011 | 27/12/2018 |
Historial de carrera de John Scarlett
Antiguos cargos conocidos de John Scarlett.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/06/2016 | 15/06/2022 |
| Independent Dir/Board Member | 01/06/2016 | 15/06/2022 | |
| CHIASMA, INC. | Director/Miembro de la Junta | 01/02/2015 | 05/08/2021 |
| Independent Dir/Board Member | 01/02/2015 | 05/08/2021 | |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Director/Miembro de la Junta | 01/02/2009 | 26/06/2009 |
| Director Ejecutivo | 01/02/2009 | 01/11/2009 | |
| Presidente | 26/06/2009 | - | |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Director/Miembro de la Junta | 01/02/2002 | 17/10/2008 |
| Director Ejecutivo | 01/02/2002 | 17/10/2008 | |
| Fundador | 01/02/2002 | 17/10/2008 | |
Sensus Drug Development Corp.
 Sensus Drug Development Corp. Pharmaceuticals: OtherHealth Technology Part of Pfizer Inc., Sensus Drug Development Corp. is a company that develops drugs to treat endocrine disorders. The company is based in San Antonio, TX. The company was founded by John A. Scarlett, Richard J. Hawkins. Sensus Drug Development was acquired by Pharmacia Corp. on March 07, 2001. | Director Ejecutivo | 01/03/1993 | 01/05/2001 |
| Fundador | 01/03/1993 | 01/05/2001 | |
| Presidente | 01/03/1993 | 01/05/2001 | |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Director/Miembro de la Junta | 01/01/1995 | 01/01/2000 |
| Fundador | 01/01/1995 | 01/01/2000 | |
Novo Nordisk Pharmaceutical Industries, Inc.
 Novo Nordisk Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Novo Nordisk Pharmaceutical Industries, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Clayton, NC. | Director Técnico/Científico/I+D | 01/01/1991 | 01/01/1993 |
Greenwich Pharmaceuticals, Inc.
 Greenwich Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Greenwich Pharmaceuticals, Inc. is an American company that specializes in commercial physical research. | Director Técnico/Científico/I+D | 01/01/1985 | 01/01/1990 |
| ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░ | - | - |
Formación de John Scarlett.
| Earlham College | Undergraduate Degree |
| Pritzker School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 14 |
Operativa
| Director/Board Member | 6 |
| Chief Executive Officer | 4 |
| Founder | 4 |
Sectorial
| Health Technology | 11 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GERON CORPORATION | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 9 |
|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Health Technology |
Sensus Drug Development Corp.
Sensus Drug Development Corp. Pharmaceuticals: OtherHealth Technology Part of Pfizer Inc., Sensus Drug Development Corp. is a company that develops drugs to treat endocrine disorders. The company is based in San Antonio, TX. The company was founded by John A. Scarlett, Richard J. Hawkins. Sensus Drug Development was acquired by Pharmacia Corp. on March 07, 2001. | Health Technology |
Novo Nordisk Pharmaceutical Industries, Inc.
Novo Nordisk Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Novo Nordisk Pharmaceutical Industries, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Clayton, NC. | Health Technology |
Greenwich Pharmaceuticals, Inc.
Greenwich Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Greenwich Pharmaceuticals, Inc. is an American company that specializes in commercial physical research. | Commercial Services |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Health Technology |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- John Scarlett
- Experiencia
